| Immune checkpoint inhibitors in colorectal cancer: challenges and future prospects S Makaremi, Z Asadzadeh, N Hemmat, A Baghbanzadeh, A Sgambato, ... Biomedicines 9 (9), 1075, 2021 | 52 | 2021 |
| The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer H Alemohammad, B Najafzadeh, Z Asadzadeh, A Baghbanzadeh, ... Biomedicine & Pharmacotherapy 146, 112516, 2022 | 46 | 2022 |
| Nanog, as a key cancer stem cell marker in tumor progression P Vasefifar, R Motafakkerazad, LA Maleki, S Najafi, F Ghrobaninezhad, ... Gene 827, 146448, 2022 | 44 | 2022 |
| Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside F Ghorbaninezhad, Z Asadzadeh, J Masoumi, A Mokhtarzadeh, T Kazemi, ... Life Sciences 297, 120466, 2022 | 19 | 2022 |
| CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro F Ghorbaninezhad, J Masoumi, M Bakhshivand, A Baghbanzadeh, ... Frontiers in Immunology, 4205, 2022 | 15 | 2022 |
| Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications F Ghorbaninezhad, P Leone, H Alemohammad, B Najafzadeh, ... International Journal of Molecular Medicine 49 (4), 1-13, 2022 | 15 | 2022 |
| Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy? F Ghorbaninezhad, H Alemohammad, B Najafzadeh, J Masoumi, ... Cancer Letters, 216168, 2023 | 12 | 2023 |
| The modulatory role of dendritic cell-T cell cross-talk in breast cancer: Challenges and prospects M Shahverdi, J Masoumi, F Ghorbaninezhad, N Shajari, F Hajizadeh, H ... Advances in Medical Sciences 67 (2), 353-363, 2022 | 5 | 2022 |
| A scoping review on the significance of PD-L1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study M Abdoli Shadbad, F Ghorbaninezhad, H Hassanian, N Karim Ahangar, ... Frontiers in Medicine, 3197, 2022 | 5* | 2022 |
| The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis M Afrashteh Nour, F Ghorbaninezhad, Z Asadzadeh, A Baghbanzadeh, ... Therapeutic Advances in Chronic Disease 14, 20406223231153572, 2023 | 1 | 2023 |
| siRNA-Mediated B7H7 Knockdown in Gastric Cancer Lysate-Loaded Dendritic Cells Amplifies Expansion and Cytokine Secretion of Autologous T Cells J Masoumi, F Ghorbaninezhad, H Saeedi, S Safaei, V Khaze Shahgoli, ... Biomedicines 11 (12), 3212, 2023 | | 2023 |
| STATs signaling pathways in dendritic cells: As potential therapeutic targets? S Sohrabi, J Masoumi, B Naseri, F Ghorbaninezhad, S Alipour, T Kazemi, ... International Reviews of Immunology, 1-22, 2023 | | 2023 |
| Analyses of kidney biomarkers in patients with sars-cov-2 (Covid-19) M Bakhshivand, F Ghorbaninezhad, T Kazemi, P Lotfinejad, V Khaze, ... Acta Medica Iranica, 168-174, 2023 | | 2023 |
| ELISA Technique: principles to diagnostic protocols F Ghorbaninezhad, M Shahpouri, M Bakhshivand, H Saeedi, H Abbasi, T Kazemi Maniyan Publishing Group 1, 125, 2023 | | 2023 |
| The Association of Elevated Levels of LDH and CK-MB with Cardiac Injury and Mortality in COVID-19 Patients F Ghorbaninezhad, M Bakhshivand, H Saeedi, N Alizadeh ImmunoAnalysis 2 (1), 8-8, 2022 | | 2022 |
| Investigation of the combined effect of immunotherapy with DCs pulsed with colorectal tumor cell lysates and CTLA-4 inhibitor on T cell response F Ghorbaninezhad Tabriz University of Medical Sciences, Faculty of Medicine, 2022 | | 2022 |
| Hemoperfusion Therapy’s Efficiency in Reducing Serum IL-6 Levels and Disease Severity in COVID-19 Patients M Bakhshivand, F Ghorbaninezhad, S Mirzayi, N Hemmat, K Ansarin, ... | | 2022 |
behzad baradaranImmunology Research Center, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir
